Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
303
Disorders of Leukocytes01:27

Disorders of Leukocytes

854
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
854
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare tumors: a blue ocean of investigation.

Frontiers of medicine·2023
Same author

Treatment of primary cutaneous lichenoid amyloidosis with abrocitinib: A pilot study in two cases.

International journal of dermatology·2023
Same author

Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis.

Frontiers in pharmacology·2023
Same author

CircHIPK2 facilitates phenotypic switching of vascular smooth muscle cells in hypertension.

Journal of human hypertension·2023
Same author

Clinical Features and Skin Microbiome of Tinea Scrotum: An Observational Study of 113 Cases in China.

Mycopathologia·2023
Same author

CRISPR-Cas12a base editors confer efficient multiplexed genome editing in rice.

Plant communications·2023
Same journal

Clinical Impact of Second Opinion Consultation in Bladder Biopsies and Transurethral Resection of Bladder Tumors.

Human pathology·2026
Same journal

Prognostic relevance and molecular correlates of Claudin-1 expression in pancreatic neuroendocrine tumors.

Human pathology·2026
Same journal

Mixed Phenotype Acute Leukemia: Lineage Assignment, Immunophenotypic Classification and Genetic Insights.

Human pathology·2026
Same journal

Chronic myelomonocytic leukemia revisited: A comprehensive review with emphasis on the oligomonocytic subtype.

Human pathology·2026
Same journal

Artificial intelligence-assisted screening for NTRK fusion-positive salivary gland tumors: A novel digital pathology workflow.

Human pathology·2026
Same journal

Evaluation of prognostic factors and outcomes in primary versus secondary myeloid sarcoma.

Human pathology·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.8K

Burkitt lymphoma.

Hong Fang1, Wei Wang1, L Jeffrey Medeiros1

  • 1Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Human Pathology
|December 11, 2024
PubMed
Summary
This summary is machine-generated.

Burkitt lymphoma is an aggressive B-cell cancer linked to Epstein-Barr virus (EBV) and MYC gene rearrangements. Recognizing its unique features is crucial for proper diagnosis and treatment.

Keywords:
Burkitt lymphomaDifferential diagnosisEpstein-barr virusMYC

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

40.2K

Related Experiment Videos

Last Updated: Jun 5, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.8K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
06:38

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines

Published on: November 8, 2011

40.2K

Area of Science:

  • Hematology
  • Oncology
  • Virology

Background:

  • Burkitt lymphoma is a distinct, aggressive B-cell neoplasm.
  • Historically linked to Epstein-Barr virus (EBV) and MYC translocations.
  • African (endemic) Burkitt lymphoma was the first neoplasm associated with a virus and a chromosomal translocation.

Purpose of the Study:

  • To provide a comprehensive review of Burkitt lymphoma.
  • To discuss its pathogenesis, clinical presentation, morphology, immunophenotype, cytogenetics, and molecular findings.
  • To highlight recent updates, including molecular pathogenesis and WHO classification changes regarding EBV association.

Main Methods:

  • Review of historical data and scientific literature.
  • Analysis of clinical, morphological, immunophenotypic, cytogenetic, and molecular findings.
  • Discussion of differential diagnoses and diagnostic criteria.

Main Results:

  • Burkitt lymphoma is characterized by a germinal center B-cell immunophenotype, high proliferation index, and MYC rearrangement.
  • EBV association is a key factor, influencing classification and potentially pathogenesis.
  • Distinguishing Burkitt lymphoma from reactive conditions and other aggressive B-cell lymphomas is critical.

Conclusions:

  • Accurate recognition of Burkitt lymphoma is essential due to its rapid growth and specific treatment requirements.
  • Understanding the molecular pathogenesis and EBV's role is advancing.
  • The classification is evolving, emphasizing EBV status over traditional epidemiologic variants.